InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Feder Julie B, 首席财务官. Officer active across 1 company, notably Aura Biosciences, Inc.. Aggregated, 9 disclosures have been logged. Split: 0 buy · 4 sells. Total volume traded: €137k. History available since 28 October 2021. The latest transaction was disclosed on 18 October 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Feder Julie B is Directeur Financier at Aura Biosciences, Inc. (XNAS). There are 9 filings in total, and across the 9 sampled filings between 2021-10-29 and 2024-10-21, sell transactions total 137342 EUR and the most frequent transaction nature is Cession.